Related by context. Frequent words. (Click for all words.) 80 multicenter 79 prospective randomized 78 multicenter randomized double 77 randomized placebo controlled 77 randomized controlled 75 placebo controlled 74 randomized 74 randomized clinical 74 blind randomized 72 blind randomized placebo 72 randomized double 72 Randomized 70 label dose escalation 69 randomized controlled clinical 67 double blind placebo 67 dose escalation trial 66 multicenter study 66 randomized controlled trial 66 Phase 1b clinical 65 randomized #:# 65 placebo controlled trials 65 dose escalation study 64 Phase 2b study 64 blind placebo controlled 64 Phase 2a clinical 64 substudy 64 phase IIb 63 randomized Phase 62 randomized clinical trials 62 Phase 2a trial 61 Phase 2b 61 randomized trials 61 non inferiority 61 dose escalation 61 Phase Ib 61 Phase 1b 61 unblinded 61 phase 2a 60 Phase 2b clinical 60 Phase IIb clinical 60 Phase 2b trial 60 randomized controlled trials 60 prospective cohort 60 Phase IIa clinical 60 mg BID 60 SPIRIT III 59 Phase IIb trial 59 bosentan 59 Phase IIb 59 investigational oral 59 pharmacodynamics 59 single ascending dose 59 rosuvastatin 59 Efficacy 59 EORTC 59 monotherapy 58 Phase IIa trial 58 multiple ascending dose 58 pioglitazone 58 metastatic renal cell carcinoma 58 lacosamide 58 BAY #-# 58 mcg kg 58 Phase III clinical 58 Myocardial Infarction 58 adalimumab 58 tiotropium 57 Phase IIa 57 relapsing remitting multiple sclerosis 57 COPAXONE R 57 dosing regimens 57 Phase 2a 57 pivotal Phase 57 ACTEMRA 57 sunitinib 57 observational study 57 CYPHER ® Stent 57 RCTs 57 telmisartan 57 tolerability 57 CYPHER R Stent 57 safety tolerability 57 Phase III pivotal 56 DURATION 56 Phase III Trial 56 composite endpoint 56 CA4P 56 clinical trial 56 thromboembolic events 56 valsartan 56 antithrombotic 56 ocular hypertension 56 tolerated dose MTD 55 epoetin alfa 55 Phase III 55 lopinavir ritonavir 55 RG# [001] 55 FOLFOX 55 abatacept 55 n = 55 lipid lowering